Paul R Minton, MD

CV: April 2021

Paul R. Minton, MD, FACC, FACP
Phone:   207-846-6555

(April 2021)


Dr. Minton, a native of Massachusetts, graduated from Boston University School of Medicine and trained in Internal Medicine at the Beth Israel Hospital, V.A. Hospital, and Tufts-New England Medical Center, all in Boston.  His Cardiology training was at the University of Colorado Medical Center, Denver. For more than 30 years, Dr. Minton has been a consultant to the legal profession as an Expert Witness currently  concentrating on:

  1. The impact of stress from work and personal injury on the heart.
  2. The role of emotional stress in myocardial infarction and sudden cardiac death.
  3. The impact of weaknesses in the Electronic Health Record (EHR) on patient care and outcomes.

Dr. Minton has active medical licenses in Georgia and in Maine.  His educational interests are: preventive cardiology;  practical anatomy of the heart; ECG interpretation; cholesterol disorders; endothelial dysfunction; congenital heart disease in the adult;  cardiac diagnosis for student and resident physicians; and non-pharmaceutical approaches to wellness.

    Maine (# MD5943) Expires October 31, 2021
    Georgia (# 71349) Expires October 31, 2021
    NPI Number: 1518966779

     DEA Number: FM8300852


2017 : National Board of Physicians and Surgeons: Diplomate of Internal        
                       Medicine  and Cardiovascular Disease

1969 : ABIM Subspecialty Board in Cardiovascular Disease (Certificate #022010)
1964:  American Board of Internal Medicine  (Certificate #022010)
1958:  National Board of Medical Examiners (Certificate #37369)


1960 -1961: Special Full-Time Graduate Student in Biochemistry, Massachusetts    
                     Institute of Technology, Cambridge, MA
1957:   M.D. Boston University School of Medicine, Boston, MA
1953:   A.M. (Biology), Boston University Graduate School, Boston, MA

1952:   A.B.  Boston University College of Liberal Arts, Boston, MA


-Impact of personal injury and work stress on heart disease and sudden cardiac death
-Weaknesses in the EHR and role in patient care and patient outcomes
-Preventive cardiology & control of cholesterol disorders
-Medical education for physicians in training including cardiac physical diagnosis
 and ECG interpretation

1999:  Distinguished Service Award, Northern New England Tri-State Chapter of the
          American College of Cardiology
1972:  Distinguished Instructor Award, Tufts University School of Medicine

1956-Present: Alpha Omega Alpha


2016 – Present:   Medical Association of Georgia

1999 – 2010:       Board Member, Northeast Cholesterol Foundation

1991 – 1997:       Member, Laennec Society, American Heart Association

1990 – 1997:       Fellow, Council on Arteriosclerosis, American Heart Association

1986:                   Chairman, Ethics Committee, Cumberland County Medical Society

1982 – 1987:       Ethics Committee, Cumberland County Medical Society

1981 – 2001:       American Society of Law, Medicine and Ethics

1977 – 1980:       Governor for Maine, American College of Cardiology

1974:                   Chairman, Subcommittee on Cardiac Surgery and Cardiac
                           Catheterization, Maine's Regional Medical Program; Cardiovascular  
                           Standards Committee

1973 – 1976:       Chairman, Maine Heart Association Continuing Education Committee

1970 – Present:  Fellow, American College of Cardiology

1969 – Present:  Fellow, American College of Physicians (Life Member)

1968 – 1999:       Maine Heart Association
1967 – Present:  Maine Medical Association

1963-1965: Lieutenant Commander,U.S. Naval Hospital, St. Albans, NY


1999: Sub Investigator:  Pravastatin Modified-Release Protocol: at Maine Cardiology Associates, Portland, ME.  (Bristol-Myers Squibb, Princeton, NJ)

1983. Project Director:  Emergency Use of MEXITIL (mexiletine hydrochloride) in Patients with Ventricular Arrhythmias; at Maine Medical Center, Portland, ME  (Boehringer Ingelheim Ltd., Ridgefield, CT)

1980-1982. Project Director:  Protocol for Emergency (Compassionate) use of Isoptin (verapamil HCl) Whenever a Patient has not Responded to, or Cannot Tolerate Conventional Therapeutic Agents; at Maine Medical Center, Portland, ME (Knoll Pharmaceutical Company, Whippany, New Jersey)

1980-1982.Project Director:Nifedipine. :A Study to Determine Efficacy in the Management of Angina Pectoris; at Maine Medical Center, Portland, Maine.  (Pfizer Pharmaceuticals, NY, NY)

1979. Project Director:  Use of Tocainide in Ventricular Arrhythmias; at Maine Medical     Center, Portland, ME.  (Astra Pharmaceutical Products, Framingham, MA)


Minton, P.R., More “What Else,” Setting the Agenda for the Clinical Interview (Letter to the Editor). Ann Intern Med., 144: 306, 2006

Brewster, T.G., Lea, D.H., Minton, P.R., Prouty, C.A.:  Cholesterol and Coronary Artery Disease:  A Physician's Manual, Maine Heart Association, 1986

Minton, P.R.:  Clinical concerns in the use of antianginal agents in Update on Anginal Therapy, A Monograph based on symposium proceedings, Boca Raton, Fl, Pfizer Laboratories, 1982, p. 93-103

Minton, P.R.:  Cardiac Transplantation:  Case Report and Current Status.  J. Maine Med. Assoc., 71:  265, 1980

Leiter, L.W., Ware, R.G., Minton, P.R., Lutes, C.A., Hiebert, C.A., & Ferguson, F.F.:  Giant cell arteritis of the aorta with dissection.  Diagnosis and Management of Dissecting Aneurysms of the Aorta.  J. Maine Med. Assoc., 60:  209, 1969

Minton, P.R., Vogel, J.H.K., Pryor, R. & Blount, S.G., Jr.:  Brain abscess in cyanotic congenital heart disease (abstract).  Am J., Cardiol., 19:  143, 1967

Bedynek, J.L., Weinstein, K.N., Kah, R.E. & Minton, P.R.:  Ventricular tachycardia.  Control by intermittent intravenous administration of lidocaine hydrochloride.  J.A.M.A., 198:  553, 1966

Raben, M.S., Matsuzaki, F. & Minton, P.R.:  Growth promoting and metabolic effects of growth hormone.  Metabolism, 13:  1102, 1964

Minton, P.R., & Raben, M.S.:  The metabolism of competing substrates in the perfused rat heart, in Memorias del IV Congreso Mundial de Cardiologia, Mexico, D.F., Galve, 1963, vol. V, p. 238

Hershman, J.M. & Minton, P.R.:  Metabolism of palmitate and glucose by the perfused hypothyroid rat heart (abstract).  Clin. Res.,
11:  220, 1963

Raben, M.S., Minton, P.R., Mitchell, M.L. & Juarez-Penalva, H.:  Metabolic effects of growth hormone in man, in Protein Metabolism, and International Symposium, Berlin, Springer-Verlag, 1962, p. 121

Minton, P.R., & Raben, M.S.:  Depression of glucose oxidation by palmitate and by acetoacetate in the perfused rat heart (abstract).  J. Clin. Invest., 41:  1385, 1962.

Minton, P.R., Zoll, P.M. & Norman, L.R.:  Levels of phosphate compounds in experimental cardiac hypertrophy.  Circulation Res.,
8: 924, 1960